Engineering a “muco-trapping” ACE2-immunoglobulin hybrid with picomolar affinity as an inhaled, pan-variant immunotherapy for COVID-19 is a research paper published in UNC Libraries (2024). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 3UL1TR002489-02S1
North Carolina Translational and Clinical Science Institute (NC TraCS)
National Institutes of Health
Grant: 1R43AI149894-01A1
Aerosol immunotherapy for treatment of human metapneumovirus infection
National Science Foundation
Grant: 2028758
RAPID: A Lung Mucus Strategy for COVID-19 Viral Protection
National Science Foundation
Grant: 1903010
Rapid: Impact of Hurricane Florence on Drinking Water Safety in Eastern and Central North Carolina: Rapid Assessment and Recommendations for Recovery and Resilience
FWCI
0.00
Citation Percentile
0.2%
Fields of Study
Keywords
Sustainable Development Goals